Abcam and Cell Marque Sign Global Strategic Marketing Agreement
News Sep 06, 2014
Abcam plc and Cell Marque Corporation have announced that they have signed a global 10-year strategic marketing agreement for Abcam’s in vitro diagnostic (IVD) immunohistochemistry (IHC) RabMAb® primary antibody portfolio.
Under the agreement, Cell Marque will apply its extensive IVD expertise to incorporate Abcam’s IVD IHC RabMAb primary antibodies into its portfolio and use its established distribution channels to distribute them to the global market. The agreement will give customers faster, easier access to Abcam’s high-quality antibodies.
The antibodies use Abcam’s powerful RabMAb technology offering superior binding affinity and specificity, and have been specifically developed to provide high-quality results to pathology laboratories for immunohistochemical staining of formalin-fixed paraffin embedded (FFPE) tissue.
Alan Hirzel, Chief Marketing Officer, Abcam, commented: “We are excited about the growth opportunity that this agreement provides. Part of our strategy is to work with partners that offer complementary high-quality products and who share our vision of enabling researchers to discover more. The agreement with Cell Marque will enable Abcam to extend its reach within the in vitro diagnostics market, with a broader range of customers able to access our in-house developed RabMAb products.”
Nora Lacey, President and CEO of Cell Marque, commented: “The addition of Abcam’s IVD RabMAb products complements our current portfolio. The agreement with Abcam demonstrates Cell Marque’s ability to meet the quality and performance requirements of pathologists and will expand our offering of exceptional quality diagnostic tools.”
Feisty Fetal T Cells Can Rebel In UteroNews
Preterm labor, a common pregnancy complication, has long been a mystery to scientists. But a new study shows it may sometimes happen when the fetal immune system “wakes up” too early and begins to reject the mother, causing the uterus to start contracting.READ MORE
Investigating Inflammasomes Implicated in Diabetic RetinopathyNews
Team of researchers employ mouse model exhibiting diabetic retinopathy symptoms that could lead to future translational research studies.READ MORE
Fat Cells Seem to Remember Unhealthy DietNews
Fat cells can be damaged in a short amount of time when they are exposed to the fatty acid palmitate or the hormone TNF-alpha through a fatty diet, a new study shows. The researchers hope this new knowledge may be used to develop new preventive strategies for diabetes.READ MORE
Comments | 0 ADD COMMENT
World Congress on Advanced Structural and Molecular Biology 2018
Aug 22 - Aug 23, 2018
Asia Pacific Congress on Probiotics, Prebiotics and Nutrition
Oct 15 - Oct 16, 2018